ProPhase Labs to Present at Investor Summit Group’s Q4 Conference
ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be participating in the Q4 Investor Summit Conference, which will take place on November 14, 2022 in New York, New York. ProPhase Labs’ CEO and Chairman of the Board of Directors, Ted Karkus will be presenting at 3:00 PM ET on November 14, 2022
By ProPhase Labs, Inc.
Published - Nov 07, 2022, 07:19 PM ET
Last Updated - Mar 22, 2024, 10:09 AM EDT
GARDEN CITY, NY, Nov. 07, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be participating in the Q4 Investor Summit Conference, which will take place on November 14, 2022 in New York, New York. ProPhase Labs’ CEO and Chairman of the Board of Directors, Ted Karkus will be presenting at 3:00 PM ET on November 14, 2022.
Event: Q4 Investor SummitDate: November 14th, 2022Presentation: November 14th at 3:00 P.M. ETLocation: Sheraton New York Times Square Hotel, 811 7th Avenue, W 53rd St, New York, NY 10019Webcast: https://us06web.zoom.us/webinar/register/WN_rAeD2KatRFKyd-GmzPBH9w
